These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32203112)

  • 1. Calcipotriol and iBRD9 reduce obesity in Nur77 knockout mice by regulating the gut microbiota, improving intestinal mucosal barrier function.
    Lv Q; Yang A; Shi W; Chen F; Liu Y; Liu Y; Wang D
    Int J Obes (Lond); 2020 May; 44(5):1052-1061. PubMed ID: 32203112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of nuciferine on gut microbiota and inflammatory response in obese model mice].
    Xiong WT; Liao JB; Yang ZX; Cui HT; Zhang ZY; Wen WB; Wang HW
    Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):2104-2111. PubMed ID: 33982526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota.
    He X; Liu J; Long G; Xia XH; Liu M
    Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsaicin Reduces Obesity by Reducing Chronic Low-Grade Inflammation.
    Yang J; Li W; Wang Y
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
    Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
    J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota disorder caused by diterpenoids extracted from Euphorbia pekinensis aggravates intestinal mucosal damage.
    Wang K; Xu X; Maimaiti A; Hao M; Sang X; Shan Q; Wu X; Cao G
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00765. PubMed ID: 34523246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
    Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH
    J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nondigestible Fructans Alter Gastrointestinal Barrier Function, Gene Expression, Histomorphology, and the Microbiota Profiles of Diet-Induced Obese C57BL/6J Mice.
    Liu TW; Cephas KD; Holscher HD; Kerr KR; Mangian HF; Tappenden KA; Swanson KS
    J Nutr; 2016 May; 146(5):949-56. PubMed ID: 27052535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.
    Hamers AA; van Dam L; Teixeira Duarte JM; Vos M; Marinković G; van Tiel CM; Meijer SL; van Stalborch AM; Huveneers S; Te Velde AA; de Jonge WJ; de Vries CJ
    PLoS One; 2015; 10(8):e0133598. PubMed ID: 26241646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colchicine increases intestinal permeability, suppresses inflammatory responses, and alters gut microbiota in mice.
    Shi Y; Li J; Yang P; Niu Z; Wei L; Chen L; Gao L
    Toxicol Lett; 2020 Nov; 334():66-77. PubMed ID: 33002524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jinzhi protects lipopolysaccharide-treated mice against mortality by repairing intestinal mucosal barrier damage and intestinal microecology.
    Xu J; Song J; Zhang Y; Wang Y; Yang L; Sha Y; Sun B; You N; Tian X; Lin R; Wu Y
    Biomed Pharmacother; 2020 Mar; 123():109749. PubMed ID: 31846840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Effects of
    Han L; Li T; Du M; Chang R; Zhan B; Mao X
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30897784
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutrophil elastase inhibitor (MPH-966) improves intestinal mucosal damage and gut microbiota in a mouse model of 5-fluorouracil-induced intestinal mucositis.
    Chen KJ; Chen YL; Ueng SH; Hwang TL; Kuo LM; Hsieh PW
    Biomed Pharmacother; 2021 Feb; 134():111152. PubMed ID: 33373916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-fat diet intake modulates maternal intestinal adaptations to pregnancy and results in placental hypoxia, as well as altered fetal gut barrier proteins and immune markers.
    Gohir W; Kennedy KM; Wallace JG; Saoi M; Bellissimo CJ; Britz-McKibbin P; Petrik JJ; Surette MG; Sloboda DM
    J Physiol; 2019 Jun; 597(12):3029-3051. PubMed ID: 31081119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolypocladium sinense Mycelium Polysaccharide Alleviates Obesity, Lipid Metabolism Disorder, and Inflammation Caused by High Fat Diet via Improving Intestinal Barrier and Modulating Gut Microbiota.
    Bai M; Wang X; Liu D; Xu A; Cheng H; Li L; Zhang C
    Mol Nutr Food Res; 2024 May; 68(9):e2300759. PubMed ID: 38651284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
    World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota.
    Chen H; Zhang F; Li R; Liu Y; Wang X; Zhang X; Xu C; Li Y; Guo Y; Yao Q
    Biomed Pharmacother; 2020 Apr; 124():109829. PubMed ID: 31958765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants.
    Willers M; Ulas T; Völlger L; Vogl T; Heinemann AS; Pirr S; Pagel J; Fehlhaber B; Halle O; Schöning J; Schreek S; Löber U; Essex M; Hombach P; Graspeuntner S; Basic M; Bleich A; Cloppenborg-Schmidt K; Künzel S; Jonigk D; Rupp J; Hansen G; Förster R; Baines JF; Härtel C; Schultze JL; Forslund SK; Roth J; Viemann D
    Gastroenterology; 2020 Dec; 159(6):2130-2145.e5. PubMed ID: 32805279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Far-Infrared Therapy Based on Graphene Ameliorates High-Fat Diet-Induced Anxiety-Like Behavior in Obese Mice via Alleviating Intestinal Barrier Damage and Neuroinflammation.
    Zhang JS; Li S; Cheng X; Tan XC; Huang YL; Dong HJ; Xue R; Zhang Y; Li JC; Feng XX; Deng Y; Zhang YZ
    Neurochem Res; 2024 Jul; 49(7):1735-1750. PubMed ID: 38530508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects: A randomized controlled trial: Arabinoxylans in gut barrier.
    Salden BN; Troost FJ; Wilms E; Truchado P; Vilchez-Vargas R; Pieper DH; Jáuregui R; Marzorati M; van de Wiele T; Possemiers S; Masclee AA
    Clin Nutr; 2018 Apr; 37(2):471-480. PubMed ID: 28214040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.